1.
Int J Part Ther
; 7(1): 54-57, 2020.
Article
in English
| MEDLINE | ID: covidwho-890734
2.
Adv Radiat Oncol
; 5(4): 743-745, 2020.
Article
in English
| MEDLINE | ID: covidwho-643814
ABSTRACT
We describe the institutional guidelines of a major tertiary cancer center with regard to using hypofractionated radiation regimens to treat glioblastoma as a measure to minimize exposure to coronavirus disease 2019 (COVID-19) while not sacrificing clinical outcomes. Our guidelines review level one evidence of various hypofractionated regimens, and recommend a multidisciplinary approach while balancing the risk of morbidity and mortality among individuals at high risk for severe illness from COVID-19 infection. We also briefly outline strategies our department is taking in mitigating risk among our cancer patients undergoing radiation.